Rationale: Polyploidy and multinucleation are characteristic features of mammalian cardiomyocytes, which develop shortly after birth when most differentiated cardiomyocytes become acytokinetic. Cardiac overload and hypertrophy further increase the degree of polyploidy of cardiomyocytes, suggesting a role in cell type-specific responses to physiological and pathological stimuli. Objective: We sought to study the function of cyclinG1 in the regulation of polyploidy and multinucleation in cardiomyocytes. Methods and Results: We found that expression of cyclinG1, a transcriptional target of p53, coincides with arrest of cardiomyocyte proliferation and onset of polyploidization. Overexpression of cyclinG1 promoted DNA synthesis but inhibited cytokinesis in neonatal cardiomyocytes leading to an enlarged population of binuclear cardiomyocytes. Reciprocally, inactivation of the cyclinG1 gene in mice lowered the degree of polyploidy and multinucleation in cardiomyocytes. Moreover, lack of cyclinG1 prevented the increase of polynucleated cardiomyocytes in response to pressure overload and hypertrophy. Conclusions: CyclinG1 is an important player for the regulation of polyploidy and multinucleation in cardiomyocytes probably by inhibition of apoptosis caused by checkpoint activation.
D uring embryonic and fetal life, myocardial mass of mammals increases by proliferation of cardiomyocytes, which synthesize DNA and undergo mitosis in the presence of myofibrils that are partially disassembled because of the resorption of Z-discs. Shortly after birth, the ability for cytokinesis ceases and is virtually absent in adult cardiomyocytes. 1 The lack of cytokinesis, however, should not be confused with a failure of cardiomyocytes to synthesize DNA. A large fraction of cardiomyocytes is able to complete a full round of DNA synthesis under conditions of cardiac overload and hypertrophy. This property is particularly evident in primates, which are able to increase the ploidy of cardiomyocytes under pathological conditions. In rodents, the ability to respond to damage by polyploidization is mostly restricted to the atrium. All mammalian species studied so far seem to own a program that allows generation of cardiomyocytes with different degrees of polyploidy after birth but the exact reason and the regulatory mechanisms which drive physiological polyploidization remain unknown. 2 In adult mice, the majority of ventricular cardiomyocytes (ca. 80%) are tetraploid and carry two nuclei (2Nϫ2, where N represents the haploid DNA content per nucleus), Ϸ8% are mono-nucleated with either 2N (Ϸ3%) or 4N (Ϸ5%), and 10% are octaploid (4Nϫ2). The remaining cells show an even higher ploidy of up to 32N. These numbers differ depending on the techniques used and individual mouse strains, which have led to some discrepancies in the literature. 3 Because polyploidization of ventricular cardiomyocytes occurs within the first three weeks of life during the same time when cardiomyocytes loose the ability to undergo cytokinesis it has been speculated that both events are caused by similar mechanism and represent two sides of the same coin. According to this view the increase of polyploidy might be a specific reaction of cardiomyocytes to respond to strong mitotic stimuli because they lack parts of the cell division machinery and therefore might adopt an abortive cell cycle mode. This hypothesis is also supported by the additional increase of the polyploidy of cardiomyocytes, which occurs in some pathological situations such as ischemic injury or end stage of heart failure that provide strong cues for cell division. 2 The accurate balance of polyploidization in different species makes it likely that polyploidization is controlled by a specific cellular program that has evolved to avoid the tetraploidy checkpoint, acquisition of multiple centromers, aberrant mitosis, and chromosomal instability, which will trigger apoptosis or uncontrolled proliferation. 4 Such a program might enable cardiomyocytes to adapt to different conditions such as hypertrophic growth, which will help to avoid potentially dangerous effects of cell divisions in the working myocardium that has to maintain a high blood pressure during the whole lifetime.
Acquisition of postmitotic fate and polyploidization of cardiomyocytes during the first weeks after birth are characterized by downregulation of cyclins and cyclin-dependent kinases (CDKs) related to G 1 /S and G 2 /M transition and upregulation of G 1 phase-related cyclins and CDKs. 5 Cyclins belong to a family of proteins, which control the progression of cells through the cell cycle by activating cyclin-dependent kinases. Several different cyclins exist, which are active in different parts of the cell cycle. There are also several "orphan" cyclins for which no Cdk partner has been identified including cyclinG1, which is a transcriptional target of p53 and involved in several p53 related processes such as apoptosis, growth control and checkpoint regulation in response to DNA damage. 6 The physiological function of cyclinG1, which is expressed in adult muscle tissues (including the heart), 7 is still largely unknown. No gross defects were reported for cyclinG1 deficient mouse strains so far, which have been established independently by two different groups. 6, 8 Here, we describe the role of cyclinG1 for the regulation of cardiomyocyte polyploidy and binucleation.
Methods
CyclinG1 knockout mice were kindly provided by Prof Thorgeirsson (NIH) and maintained on a C57BL6 background (Ͼ9 back-crossings to C57BL6). 8 Transaortic constriction (TAC) and cardiac infarction was achieved based on previously described procedures. 9 Adenoviruses expressing E2F2, LacZ and cyclinG1 were generated as described previously. 10 Cardiomyocytes from rats and mice were isolated and cultured using standard procedures. DNA content measurements by FACS were performed as described previously. 10, 11 Quantitative realtime PCR, immunofluorescence, protein isolation, Western Blot analysis, and tritiated thymidine incorporation were done using established protocols, which are described in detail in the expanded Methods section, available in the Online Data Supplement at http://circres.ahajournals.org.
Results

The Expression of CyclinG1 Coincides With the Onset of Polyploidization and Hypertrophic Growth During Postnatal Rat Cardiomyocyte Development
Cardiac development and growth might be roughly divided into 2 distinct phases, which encompass a proliferation phase during prenatal stages and a hypertrophic phase that covers the postnatal to adult period. In rodents, the switch between both phases, which is also accompanied by binucleation and polyploidization of cardiomyocytes, is completed within the first 2 weeks after birth. To identify the molecules that might be responsible for this switch, we investigated transcriptional profiles of rat hearts from embryonic day (E)18 as well as from postnatal (postnatal day [d]2) and adult (7 weeks) stages using Affymetrix DNA microarray analysis. We found that the expression of several cyclins and CDKs (cyclinA2, cyclinB1, Cdk2, and Cdk6), and mitosis-activating genes (Mad2, Plk1) were significantly downregulated in 7 weeks hearts compared to E18. In contrast, only minor changes were detected between E18 and d2 (data not shown). One of the cell-cycle related genes, which showed significant expression differences between E18 and 7 weeks, attracted our attention, because it was up-and not downregulated at 7 weeks. We found that the mRNA level of cyclinG1 increased from relatively low levels at E18 and d2 to much higher levels in 7 weeks hearts ( Figure 1A ). This observation was also confirmed by real-time PCR analysis (data not shown) and immunoblotting ( Figure 1B) . A more detailed analysis revealed that the cyclinG1 mRNA level increased strongly between d2 and d4 and was maintained at this level thereafter ( Figure 1C ). CyclinG1 protein was first detected at d4 in the heart and strongly increased by d8 ( Figure 1D ). The distinct upregulation of cyclinG1 during the early postnatal period suggested a role in cardiomyocyte maturation, which includes polyploidization, binucleation, and cessation of proliferation.
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Overexpression of CyclinG1 Moderately Accelerates G 1 /S Transition in Neonatal Rat Cardiomyocytes
To investigate whether cyclinG1 affects cell cycle exit, polyploidization, and binucleation of cardiomyocytes we overexpressed cyclinG1 using adenovirus mediated gene transfer into primary neonatal (d2) rat cardiomyocytes. We found that cyclinG1 stimulated S-phase entry of cardiomyocytes (nϭ3) 36 hours after infection. 31% of all cyclinG1 overexpressing cardiomyocytes were in S phase compared to 8% infected with a LacZ control virus ( Figure 2A ). The efficiency of cyclinG1 to induce S-phase entry was similar to E2F2 (29% cardiomyocytes in S phase), which was used as a positive control. We also wanted to know whether and to what extent cyclinG1 might modulate proproliferative signals. Therefore, neonatal rat cardiomyocytes were coinfected with cyclinG1 and E2F2, which we have described previously to strongly induce proliferation of neonatal cardiomyocytes without induction of apoptosis. 10 Interestingly, a reduced number of cardiomyocytes (15%) remained in S phase, whereas 38% of all coinfected cardiomyocytes accumulated in G 2 /M phase, indicating that coexpression of cyclinG1 and E2F2 pushed cells quickly through the S phase but restricted progression beyond the G 2 /M checkpoint (Figure 2A ). Analysis of DNA synthesis of cardiomyocytes infected with LacZ, cyclinG1, E2F2 and cyclinG1/E2F2 adenoviruses using 3 Hthymidine incorporation for 12 hours confirmed these findings ( Figure 2B ). Again, cyclinG1 overexpression significantly increased up-take of 3 H-thymidine compared to the LacZ control virus (nϭ3, PϽ0.05) although the rate of 3 H-thymidine incorporation achieved by E2F2 was much higher in this assay. Coexpression of cyclinG1 with E2F2 resulted in a further increase of 3 H-thymidine incorporation ( Figure 2B ). The quantitative differences between the FACS analysis and the 3 H-thymidine incorporation are probably attributable to different timings in both experimental settings and to the relatively long time, which it takes for neonatal cardiomyocytes to complete a cell cycle.
Western blot analysis of cell cycle regulators confirmed the induction of S-phase entry ( Figure 2C ). We detected a strong stimulation of the expression of cyclin D1 and induction of phosphorylation of Rb (Ser795) by cyclinG1, whereas E2F2 induced phosphorylation of Rb at (Ser807/811), suggesting that cyclinG1 and E2F2 increased DNA synthesis via distinct pathways. (Ser807/811) phosphorylation of RB disrupts c-abl binding (but not E2F binding), whereas (Ser795) phosphorylation is important to abolish E2F binding. 12 Both cyclinG1 and E2F2 enhanced the expression of cyclinE1. In contrast, cyclinG1 but not E2F2 induced phosphorylation of p38 and Erk, which might be responsible for the cyclinG1 mediated phosphorylation of Rb at (Ser795) and the activation of cyclin D1 expression. 13 We also noted a significant lower phosphorylation level of Rb at (Ser807/811) in E2F2/cyclinG1 coinfected cells compared to cardiomyocytes infected with E2F2 alone ( Figure 2C ), suggesting that cyclinG1 partially interfered with E2F2 mediated effects. Apparently, cyclinG1mediated phosphorylation of Rb at (Ser795) prevented E2Finduced Ser807/811 phosphorylation in coexpression experiments hence reducing the release of nuclear c-abl. Both the release of c-abl and E2F will promote G 1 /S transition albeit c-abl has also been involved in the regulation of cell cycle arrest and apoptosis depending on the cellular context. 14
Overexpression of CyclinG1 Delays Mitosis and Induces Multinucleation in Neonatal Cardiomyocytes
Initiation of DNA-synthesis and S-phase entry does not necessarily indicate that a cell undergoes mitosis and cytokinesis. 15 To investigate whether cyclinG1 stimulates or suppresses proliferation of cardiomyocytes, we measured various parameters of late mitosis and cytokinesis. Western blot analysis revealed that the mitosis markers auroraB, phosphorylated histone H3 (Ser10), Plk1, and Mad2 were all significantly repressed after overexpression of cyclinG1 in neonatal rat cardiomyocytes compared to uninfected cells and cell infected with a LacZ control virus. Moreover, concomitant expression of cyclinG1 and E2F2 efficiently inhibited E2F2 mediated upregulation of aurora B, phosphorylated histone H3 (Ser10), Plk1, and Mad2 ( Figure 3A ). We also determined the ratio of phosphorylated cofilin to total cofilin by Western blot analysis because dephosphorylation and reactivation of cofilin is critical for late stages of mitosis and cytokinesis. 16 Expression of cyclinG1 increased the ratio even in the presence of E2F2, indicating that cyclinG1 imposed a block on cytokinesis ( Figure 3B and Online Figure I ). Finally, we performed immunofluorescence staining using antibodies directed against auroraB and ␣-tubulin to directly visualize different stages of mitosis and cytokinesis in neonatal cardiomyocytes ( Figure 3D and 3E). Forced expression of cyclinG1 reduced the number of cells in cytokinesis to 0.57% compared to 0.92% observed after infection with the control virus LacZ virus. Concomitant expression of cyclinG1 and E2F2 reduced the number of cells in cytokinesis to 1.19% compared to 1.89% after infection with the E2F2 virus alone ( Figure 3C) .
A detailed analysis of cell cycle profiles by FACS analysis conducted 48 hours after expression of cyclinG1 revealed an accumulation of cardiomyocytes in G 2 /M ( Figure 4A ). In the absence of additional cell proliferation signals, the increase of the number of cells in G 2 /M was relatively modest, reaching 37% in comparison to 33% infected with the lacZ control virus and 21% infected with the E2F2 virus. Coexpression of E2F2 and cyclinG1, however, led to a massive increase of cardiomyocytes in G 2 /M phase from 21% (E2F2 alone) to 47% indicating that high levels of cyclinG1 lead to a G 2 /M arrest when proproliferative signals are present.
It is well known that an arrest at the G 2 /M check-point is unstable; normally G 2 /M-arrested cells will either undergo apoptosis or overcome the arrest and complete mitosis. To investigate whether cardiomyocytes arrested in G 2 /M upregulate apoptosis markers we studied the expression of p53 and activated caspases and performed TUNEL assays. No evidence for an upregulation of apoptosis markers or an increase of the number of apoptotic cells were found (data not shown), suggesting that cyclinG1-mediated G 2 /M arrest does not favor apoptosis. In contrast, the level of phosphorylated histone H3 (Ser10) and Plk1 increased in cyclinG1 overexpressing cells albeit at a later time point, indicating that cyclinG1 delayed rather than inhibited mitosis ( Figure 4B and Online Figure II) .
To further characterize the role of cyclinG1 for the regulation of mitosis and cytokinesis we used the flow cytometric bromodeoxyuridine-Hoechst assay, which allowed us to distinguish newly generated daughter cells from those that synthesized new DNA but did not divide. 10, 11 The effects of cyclinG1 were compared to rat cardiomyocytes infected with a LacZ control virus, in which the ratio of newly generated daughter cells was set to 100% ( Figure 4C ). Overexpression of cyclinG1 diminished the number of newly generated neonatal rat cardiomyocytes to 39%, whereas E2F2 increased the number to 175%. Coexpression of E2F2 and cyclinG1 reduced the ratio of newly generated cardiomyocytes from 175% to 59%, which illustrated the dominant role of cyclinG1 in the control of cell cycle arrest.
Mitosis is not always followed by cytokinesis in cardiomyocytes but might also result in the formation of bior multinucleated cells. We therefore assessed directly the number of binucleated cardiomyocytes, which occurred in response to cyclinG1 and E2F2 by immunofluorescence staining. Comparison to neonatal rat cardiomyocytes, which were infected with a LacZ control virus, revealed a cyclinG1-dependent increase of binuclear cardiomyocytes of 16%, whereas expression of E2F2 led to a reduction. Moreover, concomitant expression of both E2F2 and cyclinG1 resulted in 50% more binucleated cardiomyocytes compared to cardiomyocytes treated with E2F2 alone (nϭ3, 700 cardiomyocytes from 10 randomly chosen areas) ( Figure 4D and 4E) . Taken together, our results suggested that cyclinG1 had a 2-sided effect on neonatal rat cardiomyocytes: (1) it promoted DNA synthesis and G 1 /S transition; and (2) it delayed mitosis causing an accumulation in the G 2 /M phase and inhibited cytokinesis. Yet, important quantitative differences of both effects exist: the effects of cyclinG1 in imposing a G 2 /M block were stronger than induction of S phase.
Knockout of CyclinG1 Causes an Early Arrest of DNA Synthesis and Mitosis and Reduces Polyploidization of Postnatal Mouse Cardiomyocytes After Pressure-Induced Hypertrophy
To investigate the role of cyclinG1 in cell cycle regulation and polyploidization in vivo we analyzed the physiological transition from proliferative to hypertrophic growth in the postnatal myocardium of wild-type (WT) and cyclinG1 knockout mice and in response to cardiac overload and hypertrophy. Western blot analysis of isolated cardiomyocytes revealed a more rapid decrease of the expression of PCNA and phosphorylated Rb between d2 and d14 in cyclinG1 knockout mice ( Figure 5A and Online Figure  III) . Similarly, we observed a rapid downregulation of survivin, auroraB, and mad2, indicating that the loss of cyclinG1 led to precocious cell cycle exit of cardiomyocytes ( Figure 5A and Online Figure III) . We also detected an upregulation of Cks1, a Cdc2 adapter protein that promotes cyclinB1degradation, between d2 and d10, which was more pronounced in WT than in cyclinG1 knockout mice ( Figure 5A and Online Figure III) . This finding corresponds nicely to previous findings that overexpression Cks1 alters the status of the mitotic spindle cell cycle checkpoint leading to mitotic exit in the absence of chromosome segregation and cytokines and induction of polyploidization in vascular smooth muscle cells. 17, 18 It did not escape our attention that overexpression of cyclinG1 in vitro and inactivation of cyclinG1 in vivo sometimes caused similar effects (f. e. decreased levels of auroraB). We assume that some differences were caused by inherent divergences between both systems used. For our experiments we used cultures of synchronized neonatal cardio- Next, we determined the degree of polyploidy of cardiomyocytes in 14-day-old and adult mouse hearts. We observed a significant decrease of the DNA content of cyclinG1 knockout cardiomyocytes from 6N to 4N by FACS analysis (Figure 5B ). This observation was corroborated by a decreased ratio of histone H3 to pan-actin, in cyclinG1 mutant compared to WT mice, which reflects an altered nucleus/cytoplasm relationship ( Figure 5C ). To assess the number of nuclei in adult cardiomyocytes we isolated myosin heavy chain positive cardiomyocytes and stained the nuclei with DAPI ( Figure 5D ). We observed a significant reduction of polynuclear (NuϾ2) and a relative increase of the number of binuclear (Nuϭ2) cardiomyocytes in cyclinG1 knockout mice (nϭ6, 600 cardiomyocytes from 10 randomly chosen areas) ( Figure 6A ), suggesting an impaired ability of cyclinG1 mutant cardiomyocytes to undergo multinucleation. The relative decrease of nuclear material in cardiomyocytes of cy-clinG1 mutants was also reflected by the reduction of the ratio of histone 3 to pan-actin ( Figure 6C ). Next, we determined the number of cardiomyocytes in cyclinG1 and WT mice per mm 2 and measured the diameter of cardiomyocytes to rule out that the inactivation of the cyclinG1 gene, which also reduces the level of survivin (Online Figure III) , affects the number and size of cardiomyocytes.
In addition, we performed a number of Western blot experiments to determine the ratio of cardiomyocytespecific proteins to proteins found in noncardiomyocytes in the heart. In both experiments we did not find a significant difference between WT and mutant hearts suggesting that the number and size of cardiomyocytes was not significantly altered in cyclinG1 mutant compared to WT mice (Online Figure IV) .
Induction of cardiac overload and hypertrophy in WT mice by TAC revealed an increase of cardiomyocytes with multiple nuclei (NuϾ2) from 9.5Ϯ0.4% to 10.9Ϯ0.1% (PϽ0.05) and a decrease of mononucleated cardiomyocytes from 5.2Ϯ0.3% to 4.2Ϯ0.1% (PϽ0.05), whereas the number of binucleated cardiomyocytes remained constant (85.3Ϯ0.4% before and 85.0Ϯ0.1 after TAC) (nϭ6, 600 cardiomyocytes from 10 randomly chosen areas) ( Figure 6A and 6D) . In contrast, cyclinG1 mutant cardiomyocytes were characterized by a decrease of mononucleated from 6.8Ϯ0.3% to 4.0Ϯ0.1% (PϽ0.05) and polynucleated (NuϾ2) cardiomyocytes from 3.8Ϯ0.2% to 2.3Ϯ0.1% (PϽ0.05), whereas the number of binucleated cardiomyocytes increased considerably (89.4Ϯ0.4% before and 93.7Ϯ0.1 after TAC, PϽ0.05) (nϭ6, 600 cardiomyocytes from 10 randomly chosen areas) ( Figure 6A and 6D) . We reasoned that the impaired ability of cyclinG1 cardiomyocytes to undergo polyploidization prevented transition to a multinucleated state in response to pressure overload and cardiac hypertrophy. The relative decrease of the number of multinucleated (NuϾ2) cardiomyocytes ( Figure 6B and 6E ) was most likely attributable to Loading of protein was normalized to expression of pan-actin. B, Representative distribution of ploidy of cardiomyocyte nuclei at d14 (nϭ3). Results are displayed as a FACS scan (left) and as a bar chart (right). C, Quantification of expression levels of histone H3 in postnatal mouse heart ventricles at postnatal days d2 to d14 (nϭ4 for WT, nϭ4 for mutants at each time point). Protein loading was normalized to pan-actin. *PϽ0.05; **PϽ0.01 by Student's t test. D, Representative immunofluorescence image of isolated cardiomyocytes used for the analysis of ploidy in cyclinG1 mutant mice. A tetra-nucleated cardiomyocyte from WT mice is shown (myosin heavy chain and dystrophin staining in green; DAPI staining in red).
the increase of binucleated cardiomyocytes that occurred in TAC-operated cyclinG1 mutants. We would like to point out that changes in the stoichiometry of bi-and multinucleated do not necessarily require proliferation or ablation of specific cell populations because our measurements compared the relative distribution of different cell populations and not absolute numbers in the heart.
To investigate the response of cyclinG1 mutant hearts to loss of contractile tissue we ligated the left anterior descending artery (LAD) in cyclinG1 and WT control mice and measured cardiac function by MRI. We found that the end-diastolic and end-systolic volumes were significantly increased in cyclinG1 mutant compared to WT mice, which corresponded to a significantly reduced ejection fraction in mutant mice (Online Figure V) . Apparently, the lack of cyclinG1 impaired the ability of infarcted hearts to cope with the loss of contractile tissue after infarction. It was also interesting to note that the reduced ejection fraction of cyclinG1 mutant mice, which show a reduced expression of survivin (Online Figure III) , corresponds to impaired cardiac function observed in survivin deficient hearts. 19 Taken together, our results clearly demonstrate that cy-clinG1 is instrumental for the acquisition of the regular degree of polyploidization in postnatal cardiomyocytes in vivo. Lack of cyclinG1 induced a precocious exit of maturating cardiomyocytes from the cell cycle causing a reduced DNA content and a smaller number of nuclei in young and adult cardiomyocytes. Moreover, lack of cyclinG1 prevented the increase of polynucleated cardiomyocytes in response to pressure overload and hypertrophy.
Discussion
Polyploidy is a characteristic feature of some cells types in the mammalian body and coincides most often with terminal differentiation ie, with the acquisition of specialized cellular properties. 3 In addition, polyploidy can be induced by stress and injury in the cardiovascular system, 18 suggesting that polyploidization serves specific functions in these cells. 4 In fact, it has been described that increased polyploidy alters cellular physiology and enables cells to respond to specific needs. 20 Polyploidization might be particularly relevant for cells such as cardiomyocytes, which are generally unable to replicate and hence possess only limited number of options to deal with increased metabolic and biophysical stress. 21 So far, very little is known about the molecules, which activate and mediate the process of polyploidization in cardiomyocytes. Here, we have demonstrated that cyclinG1 is an important component of the machinery that controls polyploidization of cardiomyocytes based on 4 major arguments. (1) The expression of cyclinG1 during postnatal maturation of cardiomyocytes correlates with the onset of polyploidization. (2) Overexpression of cyclinG1 in primary neonatal rat cardiomyocytes increased DNA synthesis and delayed mitosis, which interfered with proliferation but enlarged the polynucleated subpopulation of cardiomyocytes. (3) Inactivation of cyclinG1 in mice caused cardiomyocytes to withdraw faster from cell cycling resulting in reduced numbers of polynucleated cells. (4) Lack of cyclinG1 prevented the increase of polynucleated cardiomyocytes in response to pressure overload and hypertrophy. The loss of cyclinG1, however, did not block polyploidization in cardiomyocytes completely, which is not surprising given the complex array of different factors and mechanisms that affect cell cycle control. Clearly, the process of polyploidization of cardiomyocytes, which involves both endoreduplication (inhibition of mitosis) and multinucleation (inhibition of cytokinesis), is controlled by multiple factors that fine tune the process while responding to physiological and pathophysiological requirements. A complete block of polyploidization might disrupt A, Number of nuclei in adult cardiomyocytes. Cardiomyocytes were isolated from 10-week-old mice, stained with antibodies against myosin heavy chain and dystrophin, and reacted with DAPI (nϭ6 for each group, Ͼ600 cardiomyocytes from 20 randomly chosen fields were counted for each individual animal). B and E, Representative immunofluorescence images of cardiomyocytes isolated from cyclinG1 mutant (B) and WT mice (E) 3 weeks after TAC (myosin heavy chain and dystrophin staining in green; DAPI staining in red). C, Quantification of expression levels of histone H3 in adult mouse heart ventricles (10 weeks) (nϭ6). Protein loading was normalized to pan-actin. D, Number of nuclei in adult cardiomyocytes 3 weeks after TAC (nϭ6 for each group, Ͼ600 cardiomyocytes from 20 randomly chosen fields were counted for each individual animal). Note the decreased number of polynucleated cardiomyocytes in cyclinG1 knockout mice. *PϽ0.05; **PϽ0.01 by Student's t test for A, C, and D.
cell cycle regulation in cardiomyocytes and hence might be incompatible with life or would require thorough cellular reprogramming.
The generation of polyploid cardiomyocytes might be viewed as a specialized type of cell cycle control, which uncouples DNA replication from cell division. During this process, cells skip mitosis and proceed through one or several rounds of DNA replication, resulting in autopolyploid cells, which do not proliferate any further. Because checkpoint activation sometimes does not persist cells might "sneak" past the arrest and produce a tetraploid cell if apoptosis is inhibited. Interestingly, cyclinG1 has been identified as a part of a negative feedback loop that down-modulates p53 activity via ARF and MDM-2. 22 Thus, it is tempting to speculate that a part of the function of cyclinG1 in polyploidization is attributable to inhibition of apoptosis caused by checkpoint activation. Further support for this hypothesis comes from the results of our myocardial infarction experiments in cyclinG1 mutant mice. The reduced ejection fraction of cyclinG1 mutant mice after MI compared to WT resembles the phenotype of mutants, which lack antiapoptotic molecules such as survivin 19 and GDF-5. 23 Another molecule, which might be involved in cyclinG1-mediated polyploidization is cyclin D1. Because cyclin D1 was significantly upregulated by overexpression of cyclinG1 in neonatal cardiomyocytes it seems reasonable to conclude that several effects of cyclinG1 such as increased numbers of cardiomyocytes in S phase as well as increased concentrations of phosphorylated Rb, E2F2, and cyclin E1 were caused by cyclin D1. This view is also supported by previous reports, which described that overexpression of cyclin D1 in cardiomyocytes induced multinucleation. 24 Our finding that cyclinG1 is instrumental for the proper control of polyploidization in cardiomyocytes is the first to uncover specific functions of a member of the cyclin family of genes for polyploidization. We propose that cyclinG1 is instrumental to convert incoming cues, which would cause proliferation in other cell types, into signals for polyploidization. In cardiomyocytes proproliferative signals often cause hypertrophy, which is tightly linked to polyploidy, suggesting that both processes are part of a program that enables cardiomyocytes to respond to specific physiological requirements. 15 Interestingly, molecules of the PI3K/Akt pathway, which plays a major role in cardiac hypertrophy, 25 have recently been described to control also the generation of binucleated tetraploid liver cells 26 and polyploidization of vascular smooth muscle cells (VSMC). 17 Although the mechanism of polyploidization in hepatocytes, VSMCs and cardiomyocytes differ this coincidence is intriguing and further illustrates the link between hypertrophy and polyploidization.
At present, it is unclear whether polyploidization represents an advantage or a disadvantage for cardiomyocytes although polyploidization has been linked to the increase of cell viability and protection from apoptosis in cardiomyocytes and hepatocytes. 27 More detailed knowledge about this process will open new ways to stimulate or prevent polyploidization in an effort to interfere with cellular decompensation and improve cardiomyocyte function.
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